In vitro Myometrial Contractility Profiles of Different Pharmacological Agents Used for Induction of Labor

 

 Buy Article Permissions and Reprints

Abstract

Objective To investigate the effects of different pharmacological induction agents on myometrial contractility.

Study Design Myometrial biopsies were obtained from 13 term nonlaboring women undergoing scheduled cesarean delivery. Tissue strips were suspended in organ chambers for isometric tension recording. The effects of cumulative doses (10⁻¹⁰ mol/L to 10⁻⁵ mol/L) of prostaglandin E1 (PGE1), E2 (PGE2), and oxytocin on spontaneous uterine contractility were determined. Areas under the contraction curve were compared using one-way analysis of variance on ranks with Dunn post hoc test.

Results Oxytocin-induced myometrial contractility was superior to PGE1, PGE2, and time controls (CTR) at all the concentrations tested. When only prostaglandins were compared with CTR, PGE1 10⁻⁵ mol/L increased myometrial contractility, and PGE2 had no effects.

Conclusion Oxytocin and prostaglandins have different effects on myometrial contractility accounting for different mechanisms of action and side effects. The increased uterine contractility observed with PGE1 as compared with PGE2 can contribute to explain the higher success of vaginal delivery.

• References

• 1 ACOG Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol 2009; 114 (2 Pt 1) 386-397
  CrossrefPubMedGoogle Scholar
• 2 Martin JA, Hamilton BE, Sutton PD. Births: final data for 2006: National vital statistics reports; vol. 57; No. 7. Hyattsville, MD: National Center for Health Statistics; 2009
  Google Scholar
• 3 Resnik JL, Resnik R. Post term pregnancy. In: Creasy RK, Resnik R, Iams JD, Lockwood JD, Moore TM, eds. Creasy & Resnik's Maternal-Fetal Medicine, Principles and Practice. 6th ed. Philadelphia: Saunders Elsevier; 2009
  Google Scholar
• 4 Xenakis EM, Piper JM, Conway DL, Langer O. Induction of labor in the nineties: conquering the unfavorable cervix. Obstet Gynecol 1997; 90: 235-239
  CrossrefPubMedGoogle Scholar
• 5 Justus Hofmeyr G. Induction of labour with an unfavourable cervix. Best Pract Res Clin Obstet Gynaecol 2003; 17: 777-794
  CrossrefPubMedGoogle Scholar
• 6 Royal College of Obstetricians and Gynaecologists. Induction of Labour. Guideline; No. 9. London, UK: RCOG Press; 2001
  Google Scholar
• 7 Stjernholm YM, Sahlin L, Eriksson HA, Byström BE, Stenlund PM, Ekman GE. Cervical ripening after treatment with prostaglandin E2 or antiprogestin (RU486). Possible mechanisms in relation to gonadal steroids. Eur J Obstet Gynecol Reprod Biol 1999; 84: 83-88
  CrossrefPubMedGoogle Scholar
• 8 Ji H, Dailey TL, Long V, Chien EK. Prostaglandin E2-regulated cervical ripening: analysis of proteoglycan expression in the rat cervix. Am J Obstet Gynecol 2008; 198: 536 , e1–e7
  PubMedGoogle Scholar
• 9 Sahlin L, Stjernholm-Vladic Y, Roos N, Masironi B, Ekman-Ordeberg G. Impaired leukocyte influx in cervix of postterm women not responding to prostaglandin priming. Reprod Biol Endocrinol 2008; 6: 36
  CrossrefPubMedGoogle Scholar
• 10 Mercer B, Pilgrim P, Sibai B. Labor induction with continuous low-dose oxytocin infusion: a randomized trial. Obstet Gynecol 1991; 77: 659-663
  PubMedGoogle Scholar
• 11 Kelly AJ, Malik S, Smith L, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2009; (4) CD003101
  PubMedGoogle Scholar
• 12 Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010; 10: CD000941
  PubMedGoogle Scholar
• 13 Fonseca L, Wood HC, Lucas MJ , et al. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin. Am J Obstet Gynecol 2008; 199: 305 , e1–e5
  PubMedGoogle Scholar
• 14 Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev 2009; (4) CD003246
  PubMedGoogle Scholar
• 15 Shojo H, Kaneko Y. Characterization and expression of oxytocin and the oxytocin receptor. Mol Genet Metab 2000; 71: 552-558
  CrossrefPubMedGoogle Scholar
• 16 Popat A, Crankshaw DJ. Variable responses to prostaglandin E(2) in human non-pregnant myometrium. Eur J Pharmacol 2001; 416: 145-152
  CrossrefPubMedGoogle Scholar
• 17 Word RA, Kamm KE, Casey ML. Contractile effects of prostaglandins, oxytocin, and endothelin-1 in human myometrium in vitro: refractoriness of myometrial tissue of pregnant women to prostaglandins E2 and F2 alpha. J Clin Endocrinol Metab 1992; 75: 1027-1032
  CrossrefPubMedGoogle Scholar
• 18 Wikland M, Lindblom B, Wilhelmsson L, Wiqvist N. Oxytocin, prostaglandins, and contractility of the human uterus at term pregnancy. Acta Obstet Gynecol Scand 1982; 61: 467-472
  CrossrefPubMedGoogle Scholar
• 19 Gordon-Wright AP, Elder MG. Effect of prostaglandin E2 and its metabolites on lower segment myometrium in vitro. Eur J Obstet Gynecol Reprod Biol 1980; 10: 297-302
  CrossrefPubMedGoogle Scholar
• 20 Cornely M, Klappstein I, Schüssler J, Rücker W, Schönhöfer PS. [Plasma levels of PGE2, PGA2 and PGF2 alpha during spontaneous labour]. Z Geburtshilfe Perinatol 1979; 183: 223-228
  PubMedGoogle Scholar
• 21 Goharkhay N, Stanczyk FZ, Gentzschein E, Wing DA. Plasma prostaglandin E(2) metabolite levels during labor induction with a sustained-release prostaglandin E(2) vaginal insert. J Soc Gynecol Investig 2000; 7: 338-342
  CrossrefPubMedGoogle Scholar
• 22 Izumi H, Garfield RE, Morishita F, Shirakawa K. Some mechanical properties of skinned fibres of pregnant human myometrium. Eur J Obstet Gynecol Reprod Biol 1994; 56: 55-62
  CrossrefPubMedGoogle Scholar
• 23 Austin SC, Sanchez-Ramos L, Adair CD. Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysis. Am J Obstet Gynecol 2010; 202: 624 , e1–e9
  PubMedGoogle Scholar
• 24 American College of Obstetricians and Gynecologists. Practice bulletin no. 116: Management of intrapartum fetal heart rate tracings. Obstet Gynecol 2010; 116: 1232-1240
  CrossrefPubMedGoogle Scholar